Sun Pharmaceutical Industries Ltd., the Indian multinational pharmaceutical company, which manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries worldwide is recalling approximately 55,000 bottles of a generic medication used to treat gout from the American market. This recall is due to deviations from the current Good Manufacturing Practice Regulations (CGMP) norms, as per the US health regulator. The New Jersey-based unit is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, according to the US Food and Drug Administration
Sun Pharmaceutical Industries Ltd., the Indian multinational pharmaceutical company, which manufactures and sells pharmaceutical formulations and active pharmaceutical ingredients in more than 100 countries worldwide is recalling approximately 55,000 bottles of a generic medication used to treat gout from the American market. This recall is due to deviations from the current Good Manufacturing Practice Regulations (CGMP) norms, as per the US health regulator. The New Jersey-based unit is recalling Febuxostat Tablets in 40 mg and 80 mg strengths, according to the US Food and Drug Administration (USFDA). Tehatta, West Bengal; India.
Size: 6048px × 4024px
Photo credit: © Ricky Simms / Alamy / Afripics
License: Licensed
Model Released: No
Keywords: administration, american, bengal, capsules, company, drug, drugs, febuxostat, food, formulations, generic, good, gout, health, india, indian, industries, ingredients, manufacturing, market, mecal, medication, medicine, multinational, pharmaceutical, practice, regulations, regulator, sun, tablets, tehatta, west
